Showing results (371-380 of 391) with videos related to

Sort By:
Pageof 40
Arthritis & Rheumatology (Hoboken, N.J.)|September 26, 2018
Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association StudyRaquel López-Mejías, F David Carmona, Fernanda Genre, et al.
Seminars in Arthritis and Rheumatism|June 8, 2020
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER)Vicenç Torrente-Segarra, Tarek C Salman-Monte, Íñigo Rúa-Figueroa, et al.
Seminars in Arthritis and Rheumatism|February 10, 2018
Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patientsCarlos Fernández-Díaz, Javier Loricera, Santos Castañeda, et al.
Rheumatology (Oxford, England)|December 7, 2019
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER RegistryNatalia Mena-Vázquez, Antonio Fernández-Nebro, José María Pego-Reigosa, et al.
Rheumatology (Oxford, England)|June 10, 2025
Baricitinib in rheumatoid arthritis-interstitial lung disease: national multicenter study of 72 patients and literature reviewAna Serrano-Combarro, Belén Atienza-Mateo, Adrián Martín-Gutiérrez, et al.
Lupus Science & Medicine|December 23, 2025
Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortalityIrene Altabás-González, Iñigo Rua-Figueroa, Karen Roberts, et al.
Therapeutic Advances in Musculoskeletal Disease|July 2, 2021
Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature reviewDiana Prieto-Peña, Pilar Bernabeu, Paloma Vela, et al.
Seminars in Arthritis and Rheumatism|July 27, 2024
Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patientsMarta López-Maraver, Ana Serrano-Combarro, Belén Atienza-Mateo, et al.
Lupus Science & Medicine|April 8, 2024
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohortIñigo Rua-Figueroa, M Jesus García de Yébenes, Julia Martinez-Barrio, et al.
Medicine|January 9, 2015
Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differencesÍñigo Rúa-Figueroa, Patricia Richi, Francisco Javier López-Longo, et al.
Pageof 40